Intra Cellular Therapies | 债务

Debt 更改 日
Acadia Pharmaceuticals USD 59.64M 59.64M 2024-03
ALKERMES USD 370.11M 79.38M 2024-03
Biogen USD 6.95B 8.4M 2024-03
Bristol-Myers Squibb USD 57.41B 17.64B 2024-03
Cytokinetics USD 754.92M 136.46M 2024-03
Gilead Sciences USD 25.19B 212M 2024-03
Halozyme Therapeutics USD 1.5B 1.63M 2024-03
Intra Cellular Therapies USD 16.38M 16.38M 2024-03
J&J USD 33.63B 3.71B 2024-03
Neurocrine Biosciences USD 511.9M 342M 2024-03
Novartis USD 27.28B 936M 2024-03
Prothena USD 12.5M 12.5M 2024-03
RedHill Biopharma USD 2.28M 4.71M 2023-06
Supernus Pharmaceuticals USD 42.13M 438.74M 2024-03
United Therapeutics USD 600M 100M 2024-03



Intra Cellular Therapies 债务 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.